320 related articles for article (PubMed ID: 20660191)
41. LANA and hnRNP A1 Regulate the Translation of LANA mRNA through G-Quadruplexes.
Dabral P; Babu J; Zareie A; Verma SC
J Virol; 2020 Jan; 94(3):. PubMed ID: 31723020
[TBL] [Abstract][Full Text] [Related]
42. Accumulation of heterochromatin components on the terminal repeat sequence of Kaposi's sarcoma-associated herpesvirus mediated by the latency-associated nuclear antigen.
Sakakibara S; Ueda K; Nishimura K; Do E; Ohsaki E; Okuno T; Yamanishi K
J Virol; 2004 Jul; 78(14):7299-310. PubMed ID: 15220403
[TBL] [Abstract][Full Text] [Related]
43. KSHV LANA--the master regulator of KSHV latency.
Uppal T; Banerjee S; Sun Z; Verma SC; Robertson ES
Viruses; 2014 Dec; 6(12):4961-98. PubMed ID: 25514370
[TBL] [Abstract][Full Text] [Related]
44. LANA oligomeric architecture is essential for KSHV nuclear body formation and viral genome maintenance during latency.
De Leo A; Deng Z; Vladimirova O; Chen HS; Dheekollu J; Calderon A; Myers KA; Hayden J; Keeney F; Kaufer BB; Yuan Y; Robertson E; Lieberman PM
PLoS Pathog; 2019 Jan; 15(1):e1007489. PubMed ID: 30682185
[TBL] [Abstract][Full Text] [Related]
45. The Latency-Associated Nuclear Antigen of Kaposi's Sarcoma-Associated Herpesvirus Inhibits Expression of SUMO/Sentrin-Specific Peptidase 6 To Facilitate Establishment of Latency.
Lin X; Sun R; Zhang F; Gao Y; Bin L; Lan K
J Virol; 2017 Sep; 91(17):. PubMed ID: 28615201
[TBL] [Abstract][Full Text] [Related]
46. Kaposi's Sarcoma-Associated Herpesvirus Latency-Associated Nuclear Antigen: Replicating and Shielding Viral DNA during Viral Persistence.
Weidner-Glunde M; Mariggiò G; Schulz TF
J Virol; 2017 Jul; 91(14):. PubMed ID: 28446671
[TBL] [Abstract][Full Text] [Related]
47. KSHV encoded LANA recruits Nucleosome Assembly Protein NAP1L1 for regulating viral DNA replication and transcription.
Gupta N; Thakker S; Verma SC
Sci Rep; 2016 Sep; 6():32633. PubMed ID: 27599637
[TBL] [Abstract][Full Text] [Related]
48. Kaposi's Sarcoma-Associated Herpesvirus Hijacks RNA Polymerase II To Create a Viral Transcriptional Factory.
Chen CP; Lyu Y; Chuang F; Nakano K; Izumiya C; Jin D; Campbell M; Izumiya Y
J Virol; 2017 Jun; 91(11):. PubMed ID: 28331082
[TBL] [Abstract][Full Text] [Related]
49. Latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus recruits uracil DNA glycosylase 2 at the terminal repeats and is important for latent persistence of the virus.
Verma SC; Bajaj BG; Cai Q; Si H; Seelhammer T; Robertson ES
J Virol; 2006 Nov; 80(22):11178-90. PubMed ID: 16928741
[TBL] [Abstract][Full Text] [Related]
50. The 3D structure of Kaposi sarcoma herpesvirus LANA C-terminal domain bound to DNA.
Hellert J; Weidner-Glunde M; Krausze J; Lünsdorf H; Ritter C; Schulz TF; Lührs T
Proc Natl Acad Sci U S A; 2015 May; 112(21):6694-9. PubMed ID: 25947153
[TBL] [Abstract][Full Text] [Related]
51.
Pires de Miranda M; Quendera AP; McVey CE; Kaye KM; Simas JP
J Virol; 2018 Nov; 92(21):. PubMed ID: 30111565
[TBL] [Abstract][Full Text] [Related]
52. Disentangling the molecular determinants for Cenp-F localization to nuclear pores and kinetochores.
Berto A; Yu J; Morchoisne-Bolhy S; Bertipaglia C; Vallee R; Dumont J; Ochsenbein F; Guerois R; Doye V
EMBO Rep; 2018 May; 19(5):. PubMed ID: 29632243
[TBL] [Abstract][Full Text] [Related]
53. The Kaposi Sarcoma Herpesvirus Latency-associated Nuclear Antigen DNA Binding Domain Dorsal Positive Electrostatic Patch Facilitates DNA Replication and Episome Persistence.
Li S; Tan M; Juillard F; Ponnusamy R; Correia B; Simas JP; Carrondo MA; McVey CE; Kaye KM
J Biol Chem; 2015 Nov; 290(47):28084-28096. PubMed ID: 26420481
[TBL] [Abstract][Full Text] [Related]
54. Kaposi's sarcoma-associated herpesvirus LANA recruits the DNA polymerase clamp loader to mediate efficient replication and virus persistence.
Sun Q; Tsurimoto T; Juillard F; Li L; Li S; De León Vázquez E; Chen S; Kaye K
Proc Natl Acad Sci U S A; 2014 Aug; 111(32):11816-21. PubMed ID: 25071216
[TBL] [Abstract][Full Text] [Related]
55. The minimal replicator element of the Kaposi's sarcoma-associated herpesvirus terminal repeat supports replication in a semiconservative and cell-cycle-dependent manner.
Verma SC; Choudhuri T; Robertson ES
J Virol; 2007 Apr; 81(7):3402-13. PubMed ID: 17151118
[TBL] [Abstract][Full Text] [Related]
56. Latent nuclear antigen of Kaposi's sarcoma herpesvirus/human herpesvirus-8 induces and relocates RING3 to nuclear heterochromatin regions.
Mattsson K; Kiss C; Platt GM; Simpson GR; Kashuba E; Klein G; Schulz TF; Szekely L
J Gen Virol; 2002 Jan; 83(Pt 1):179-188. PubMed ID: 11752715
[TBL] [Abstract][Full Text] [Related]
57. Determination of Kaposi's sarcoma-associated herpesvirus C-terminal latency-associated nuclear antigen residues mediating chromosome association and DNA binding.
Kelley-Clarke B; Ballestas ME; Srinivasan V; Barbera AJ; Komatsu T; Harris TA; Kazanjian M; Kaye KM
J Virol; 2007 Apr; 81(8):4348-56. PubMed ID: 17287261
[TBL] [Abstract][Full Text] [Related]
58. Latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus (KSHV) upregulates survivin expression in KSHV-Associated B-lymphoma cells and contributes to their proliferation.
Lu J; Verma SC; Murakami M; Cai Q; Kumar P; Xiao B; Robertson ES
J Virol; 2009 Jul; 83(14):7129-41. PubMed ID: 19439469
[TBL] [Abstract][Full Text] [Related]
59. Kaposi's sarcoma-associated herpesvirus induces the ATM and H2AX DNA damage response early during de novo infection of primary endothelial cells, which play roles in latency establishment.
Singh VV; Dutta D; Ansari MA; Dutta S; Chandran B
J Virol; 2014 Mar; 88(5):2821-34. PubMed ID: 24352470
[TBL] [Abstract][Full Text] [Related]
60. The single RBP-Jkappa site within the LANA promoter is crucial for establishing Kaposi's sarcoma-associated herpesvirus latency during primary infection.
Lu J; Verma SC; Cai Q; Robertson ES
J Virol; 2011 Jul; 85(13):6148-61. PubMed ID: 21507979
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
